// App-Quantinova.ai

: CARDIOPROTECTIVE EFFECTS OF ATORVASTATIN IN B-CELL LYMPHOMA PATIENTS RECEIVING RCHOP REGIMEN, A RANDOMIZED CONTROLLED TRIAL

Researchers

Presenter

  • Atisa Koonarat

Principal Investigators

  • Lalita Norasetthada

  • Chatree Chai-Adisaksopha

  • Adisak Tantiworawit

  • Ekarat Rattarittamrong

  • Thanawat Rattanathammethee

  • Lalita Yongsmith

  • Wanwarang Wongcharoen

  • Arintaya Phrommintikul

  • Nattayaporn Apaijai

  • Siriporn Chattipakorn

  • Nipon Chattipakorn

Medical Centers

  • Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand

  • Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand

  • Department of Surgery, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand

Locations

  • Thailand

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • B cell lymphomas

Biomarkers

  • B-type natriuretic peptide

Drug/Treatment

  • Atorvastatin

Outcome

  • N/A

Study Design

  • Randomized

  • Multinational

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved